compounded glp-1 Noom offers cut-price drug for obesity Compounded GLP-1s: Why doctors worry

Suppression failure of cortisol secretion by dexamethasone may occur in glucagon-like peptide-1 receptor agonist-treated patients with diabetic autonomic neuropathy

Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects

A.AxsonS

Expert Opinions and Guidelines Endocrinologists and obesity experts emphasize that GLP-1 therapies are effective but require ongoing monitoring, tailored dosing, and lifestyle support

For instance, angiotensin converting enzyme inhibitors (ACEI), now a cornerstone for hypertension treatment, initially led to severe hypotension in dehydrated patients due to a lack of understanding of their potent effects